CLINICAL OUTCOMES OF ACUTE EXACERBATION OF COPD IN INFLUENZA ACCORDING TO VACCINATION STATUS IN PATIENTS ABOVE AGE 65 YEARS
DOI:
https://doi.org/10.71000/hmzhp140Keywords:
Aged, Chronic Obstructive Pulmonary Disease, Hospital Mortality, Influenza Vaccines, Length of Stay, Preventive Health Services, Respiratory Tract Infections.Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality in the elderly, with acute exacerbations frequently triggered by respiratory infections such as influenza. Vaccination against influenza is globally recommended in this population; however, real-world evidence regarding its impact on clinical outcomes remains limited in low-resource settings.
Objective: To assess and compare clinical outcomes, particularly in-hospital mortality and length of hospital stay, in elderly patients (≥65 years) with acute exacerbation of COPD, based on their influenza vaccination status.
Methods: This descriptive study was conducted at the Department of Medicine, Khyber Teaching Hospital, Peshawar, over a 6-month period. A total of 112 patients aged 65 to 80 years, hospitalized with acute COPD exacerbation, were enrolled and divided equally into vaccinated and unvaccinated groups based on verified influenza vaccination status. Key outcomes included in-hospital mortality and prolonged hospital stay (>5 days). Data were collected prospectively and analyzed using SPSS v24, with p≤0.05 considered statistically significant.
Results: Among the vaccinated group (n=56), in-hospital mortality was 5.4% compared to 16.1% in the unvaccinated group. Prolonged hospital stays were observed in 12.5% of vaccinated patients versus 32.1% in unvaccinated patients. The mean hospital stay was significantly shorter in vaccinated individuals (4.2 ± 1.6 days) than in the unvaccinated group (6.3 ± 2.4 days), indicating a clear protective association of influenza vaccination.
Conclusion: Influenza vaccination was significantly associated with reduced mortality and shorter hospital stays in elderly COPD patients experiencing acute exacerbations. These findings reinforce the urgent need to improve vaccination coverage in high-risk elderly populations.
References
Boesing M, Albrich W, Bridevaux PO, Charbonnier F, Clarenbach C, Fellrath JM, et al. Vaccination in adult patients with chronic lung diseases. Praxis (Bern 1994). 2024;113(11-12):297-305.
Kpozehouen EB, Tan T, Macintyre CR. Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation. Vaccine. 2022;40(52):7709-13.
Simon S, Joean O, Welte T, Rademacher J. The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus. Eur Respir Rev. 2023;32(169).
Zysman M, Coquelin A, Le Guen N, Solomiac A, Guecamburu M, Erbault M, et al. Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study. Respir Med. 2024;226:107606.
Saeed GJ, Valero-Elizondo J, Mszar R, Grandhi GR, Cainzos-Achirica M, Omer SB, et al. Prevalence and Disparities in Influenza Vaccination Among Patients With COPD in the United States. Chest. 2021;159(4):1411-4.
Jeong H, Kim SH, Choi S, Kim H. Nonadherence to health promotion depending on chronic obstructive pulmonary disease severity. Heart Lung. 2022;55:1-10.
Young-Xu Y, Smith J, Nealon J, Mahmud SM, Van Aalst R, Thommes EW, et al. Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans. PLoS One. 2022;17(1):e0262072.
Tippett A, Ess G, Hussaini L, Reese O, Salazar L, Kelly M, et al. Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults. Clin Infect Dis. 2024;78(4):1065-72.
Chung H, Buchan SA, Campigotto A, Campitelli MA, Crowcroft NS, Dubey V, et al. Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010-2011 to 2015-2016 Seasons in Ontario, Canada. Clin Infect Dis. 2021;73(5):e1191-e9.
Wang Y, Xu W, Jin C, Wang S, Yan Q, Wu F, et al. Influenza Vaccination and Short-Term Risk of Stroke Among Elderly Patients With Chronic Comorbidities in a Population-Based Cohort Study. J Clin Hypertens (Greenwich). 2025;27(8):e70044.
Yang WK, Shao SC, Liu CC, Chi CC. Influenza vaccination and risk of dementia: a systematic review and meta-analysis. Age Ageing. 2025;54(7).
Bazargan M, Wisseh C, Adinkrah E, Ameli H, Santana D, Cobb S, et al. Influenza Vaccination among Underserved African-American Older Adults. Biomed Res Int. 2020;2020:2160894.
Raherison C, Aguilaniu B, Zysman M, Burgel PR, Hess D, Ouaalaya EH, et al. Influenza and pneumococcal vaccination in patients with COPD from 3 French cohorts: Insufficient coverage and associated factors. Respir Med Res. 2024;86:101112.
He R, Ren X, Huang K, Lei J, Niu H, Li W, et al. Influenza and pneumococcal vaccination coverage and associated factors in patients hospitalized with acute exacerbations of COPD in China: Findings from real-world data. Chin Med J (Engl). 2024;137(10):1179-89.
Liu C, Song Q, Lin L, Li T, Zhang P, Zeng Y, et al. Impact of intensive health education on influenza vaccination and acute exacerbations in outpatients with chronic obstructive pulmonary disease: a real-world study. J Glob Health. 2025;15:04047.
Allen B, Aboussouan LS. Diagnostic and therapeutic challenges of chronic obstructive pulmonary disease in the elderly. Curr Opin Pulm Med. 2021;27(2):113-9.
Bazargan M, Martinez-Hollingsworth A, Cobb S, Kibe LW. Correlates of influenza vaccination among underserved Latinx middle-aged and older adults: a cross-sectional survey. BMC Public Health. 2022;22(1):907.
Kostinov M, Chuchalin A, Chebykina A, Khrapunova I, Cherdantsev A, Solov'eva I, et al. Clinical status and cytokine profiles in patients with asthma or chronic obstructive pulmonary disease vaccinated against influenza. PLoS One. 2025;20(2):e0313539.
Liang C, Mao X, Niu H, Huang K, Dong F, Chen Y, et al. Characteristics, Management and In-Hospital Clinical Outcomes Among Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: Results from the Phase I Data of ACURE Study. Int J Chron Obstruct Pulmon Dis. 2021;16:451-65.
Chong KC, Chen Y, Chan EYY, Lau SYF, Lam HCY, Wang P, et al. Association of weather, air pollutants, and seasonal influenza with chronic obstructive pulmonary disease hospitalization risks. Environ Pollut. 2022;293:118480.
Parente DJ, Murray MJ, Woodward J. Association Between Unmet Essential Social Needs and Influenza Vaccination in US Adults. J Gen Intern Med. 2022;37(1):23-31.
Gogou E, Hatzoglou C, Zarogiannis SG, Siachpazidou D, Gerogianni I, Kotsiou OS, et al. Are younger COPD patients adequately vaccinated for influenza and pneumococcus? Respir Med. 2022;203:106988.
Kositanont U, Wongsurakiat P, Pooruk P, Maranetra N, Puthavathana P. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients. Viral Immunol. 2020; 23(3):329-34.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Qaiser Wadud, Zahid Mohammad Wazir , Nayab Sami, Farid Ullah , Almas Khan, Israr Muhammad (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
